Pulmonx Corp (LUNG) financials · rev $90.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Pulmonx Corp (LUNG) rev $90.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $90.5M | $83.8M |
| Cost of Revenue | $23.4M | $21.8M |
| Gross Profit | $67.1M | $62.0M |
| Operating Income | -$53.7M | -$57.7M |
| Net Income | -$54.0M | -$56.4M |
| EPS (Diluted) | -$1.33 | -$1.44 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $129.3M | $162.8M |
| Current Assets | $101.7M | $136.2M |
| Cash & Equivalents | $69.8M | $70.9M |
| Inventory | $15.8M | $16.9M |
| PP&E | $2.22M | $2.91M |
| Total Liabilities | $75.2M | $77.0M |
| Current Liabilities | $20.1M | $24.4M |
| Short-term Debt | $106.0K | $3.18M |
| Long-term Debt | $37.0M | $34.0M |
| Total Debt | $37.1M† | $37.2M† |
| Shareholders' Equity | $54.1M | $85.8M |
| Retained Earnings | -$521.6M | -$467.6M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$32.4M | -$31.5M |
| CapEx | $452.0K | $1.45M |
| Investing Cash Flow | $30.5M | $17.5M |
| Financing Cash Flow | $833.0K | $1.36M |
| Net Change in Cash | -$1.15M | -$12.6M |
| Free Cash Flow | -$32.8M | -$33.0M |
FAQ
What is LUNG P/E and revenue?
Pulmonx Corp (LUNG) rev $90.5M.
What is LUNG revenue?
Pulmonx Corp last cached revenue is $90.5M (FY2025).
Is LUNG profitable?
Pulmonx Corp last cached net income is -$54.0M (FY2025).
What are LUNG total assets?
Pulmonx Corp last cached total assets are $129.3M (FY2025).
What is LUNG free cash flow?
Pulmonx Corp last cached free cash flow is -$32.8M (FY2025).
Not investment advice. Cached statements, not a live tape.